National Institutes of Health director Dr. Francis Collins will step down by the end of 2021. Collin, who was appointed by President Obama in 2009, led the NIH for 12 years. (CNBC Weekly)

AstraZeneca is seeking emergency approval from the Food and Drug Administration for its COVID-19 antibody cocktail. The treatment, AZD7442, places antibodies in the body to protect against the virus. (Reuters)

The cost of COVID-19 treatments varies significantly from patient to patient, a new analysis found. One patient with a severe respiratory illness may be charged $11,000, while another with the same condition could be charged upwards of $43,000 depending on hospital and insurance coverage. (The Wall Street Journal)

GlaxoSmithKline is reducing its office space in Philadelphia by 75% and in North Carolina’s Research Triangle Park by 90%. The downsizing reflects the company’s belief that only about 50% of employees will work in office settings on a regular basis. (Endpoints News)

Carbon Health has acquired remote monitoring startup Alertive Healthcare. Carbon joins digital-first companies like Teladoc and Ro, both of which have recently made acquisitions in continuous care and home diagnostics. (STAT)